1,424 reports of this reaction
1.8% of all ARIPIPRAZOLE ORAL reports
#9 most reported adverse reaction
FATIGUE is the #9 most commonly reported adverse reaction for ARIPIPRAZOLE ORAL, manufactured by Accord Healthcare, Inc.. There are 1,424 FDA adverse event reports linking ARIPIPRAZOLE ORAL to FATIGUE. This represents approximately 1.8% of all 79,930 adverse event reports for this drug.
Patients taking ARIPIPRAZOLE ORAL who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is a less commonly reported adverse event for ARIPIPRAZOLE ORAL, but still significant enough to appear in the safety profile.
In addition to fatigue, the following adverse reactions have been reported for ARIPIPRAZOLE ORAL:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 1,424 FDA reports for ARIPIPRAZOLE ORAL. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 1.8% of all adverse event reports for ARIPIPRAZOLE ORAL, making it a notable side effect.
If you experience fatigue while taking ARIPIPRAZOLE ORAL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.